Home › Calculator › AFMDQ Dividend Calculator 2026
AFMDQ Dividend DRIP Calculator 2026
2000000.00% YieldHealthcareAffimed N.V. · PNK
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When AFMDQ pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your AFMDQ snowball 📈
$10,000 in AFMDQ → $3.603059672953261e+54M in 10 years · $300,254,958,085,218,450,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
About Affimed N.V. (AFMDQ) — Dividend Analysis 2026
Affimed N.V. operates as a clinical-stage biopharmaceutical firm, dedicated to the discovery and advancement of immunotherapies targeting cancer across both the United States and Germany. Its primary therapeutic candidates include AFM13, which has successfully concluded Phase 2 trials for CD30-positive lymphoma, Phase 1b for Hodgkin lymphoma, and Phase 2b clinical evaluation for peripheral T-cell lymphoma. Another key candidate, AFM24, a tetravalent, bispecific innate cell engager designed to bind epidermal growth factor receptor and CD16A, is currently undergoing a Phase 2a clinical trial for patients with advanced malignancies. Additionally, AFM28, another innate cell engager (ICE), is in preclinical stages for addressing acute myeloid leukemia. Similarly, AFM32, an ICE candidate, is progressing through preclinical development for solid tumor indications. The company also maintains a collaborative partnership with Artiva Biotherapeutics, aiming to develop the combined therapy of acimtamig and AlloNK. Furthermore, a licensing and strategic alliance with Roivant Sciences Ltd. focuses on the development and commercialization of new ICE molecules, notably AFM32, within the field of oncology. A strategic collaboration with Genentech is also in place for advancing specific product candidates, encompassing novel NK cell engager-based immunotherapeutic agents designed to combat a range of cancers. Formerly named Affimed Therapeutics B.V., the entity adopted its current moniker, Affimed N.V., in October 2014. Established in 2000, its corporate headquarters are situated in Mannheim, Germany.
Compare AFMDQ with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full AFMDQ DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AFMDQ position with:
🌍 AFMDQ Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold AFMDQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| 🇨🇦 TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| 🇫🇷 FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 AFMDQ Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 AFMDQ Dividend Payment Schedule
AFMDQ pays quarterly — 4 times per year. Next ex-div: TBD.
📊 AFMDQ vs Healthcare Benchmarks
How AFMDQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AFMDQ sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ AFMDQ Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where AFMDQ earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AFMDQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Affimed N.V. (AFMDQ) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 2000000.00% based on an annual payout of $2.00 per share.
AFMDQ (Affimed N.V.) — 2000000.00% Dividend Yield Analysis
Affimed N.V. (AFMDQ) is a healthcare stock currently trading at $0.00 with a dividend yield of 2000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (2000000.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.